Pacira BioSciences Acquires Remaining 81% Equity Stake Of GQ Bio Therapeutics For About $32 Mln
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Pacira BioSciences Inc. (PCRX) said that it has acquired the remaining 81 percent equity stake of GQ Bio Therapeutics GmbH for about $32 million, net of working capital and other transaction adjustments, to equity holders other than Pacira. The net purchase price incl
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2107841922-5be74c310a4d436a84276f5c123b69fc.jpg "The Surprising Truth About 60-Year-Olds’ 401(k) Balances in Today’s Market")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1337933770-0bc45c03fdc949af95aced9f2ea16fd2.jpg "5 Ways to Start Generation Beta on the Right Financial Foot")